SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001171843-12-002035
Filing Date
2012-05-29
Accepted
2012-05-29 16:34:29
Documents
11
Period of Report
2012-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 40-F f40f_052912.htm 40-F 65344
2 EXHIBIT 99.1 exh_991.htm EX-99.1 592854
3 EXHIBIT 99.2 exh_992.htm EX-99.2 3104689
4 EXHIBIT 99.3 exh_993.htm EX-99.3 872038
5 EXHIBIT 99.4 exh_994.htm EX-99.4 9124
6 EXHIBIT 99.5 exh_995.htm EX-99.5 20410
7 EXHIBIT 99.6 exh_996.htm EX-99.6 10850
8 exh_9940.jpg GRAPHIC 2897
9 exh_9941.jpg GRAPHIC 4108
10 logo2.gif GRAPHIC 7251
11 chart.gif GRAPHIC 7254
  Complete submission text file 0001171843-12-002035.txt   4706464
Mailing Address 225 PROMENADE DU CENTROPOLIS SUITE 200 LAVAL A8 H7T 0B3
Business Address 225 PROMENADE DU CENTROPOLIS SUITE 200 LAVAL A8 H7T 0B3 (450) 687-2262
Neptune Technologies & Bioressources Inc. (Filer) CIK: 0001401395 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0228
Type: 40-F | Act: 34 | File No.: 001-33526 | Film No.: 12874648
SIC: 2834 Pharmaceutical Preparations